20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
The New York City Commission on Human Rights (NYCCHR) has released a factsheet providing guidance on...
Read More >
Due to pressure from construction workers, officials, and some construction workers having tested po...
Read More >
Welcome to the twelfth survey of sponsor-backed going private transactions prepared by Weil, Gotshal...
Read More >
Merger review processes are being impacted worldwide as merger control authorities adapt to take acc...
Read More >
The new National Security and Investment Bill, which aims to provide the Government with the necessa...
Read More >
In its final part 541 overtime rule, the U.S. Department of Labor’s (DOL) Wage and Hour Division (W...
Read More >